Clinical Trials List
2025-05-01 - 2026-01-30
Others
Recruiting4
ICD-10E79.0
Hyperuricemia without signs of inflammatory arthritis and tophaceous disease
ICD-10R73.9
Hyperglycemia, unspecified
ICD-10R78.71
Abnormal lead level in blood
ICD-10R78.79
Finding of abnormal level of heavy metals in blood
ICD-10R78.89
Finding of other specified substances, not normally found in blood
ICD-10R79.0
Abnormal level of blood mineral
ICD-10R79.89
Other specified abnormal findings of blood chemistry
ICD-10R79.9
Abnormal finding of blood chemistry, unspecified
ICD-9790.6
Other abnormal blood chemistry
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- 李向嚴 無
- Hsi-Hsien Chen Division of Nephrology
- Chih-Chin Kao Division of Nephrology
- Chi-Ching Chang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ping-Han Tsai 無
- 楊皇煜 無
- Chen-I Hsieh 無
- Yao-Fan Fang 無
- Yun Chen Tsai 無
- 陳彥輔 無
- 蕭朝陽 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
60 participants
